Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 68 Neoplasms 25 Breast Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 13 Lung Neoplasms 12 Head and Neck Neoplasms 11 Neoplasm Metastasis 8 Carcinoma, Squamous Cell 7 Pancreatic Neoplasms 6 Colorectal Neoplasms 6 Stomach Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Prostatic Neoplasms 4 Multiple Myeloma 4 Esophageal Neoplasms 4 Lymphoma 3 Hematologic Neoplasms 3 Glioblastoma 3 Brain Neoplasms 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Non-small-cell Lung Cancer With Somatic EGFR Mutations 2 NSCLC 2 Melanoma 2 Glioma 2 Colonic Neoplasms 2 Adenocarcinoma of Lung 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1

Interventions

Nivolumab 6 Imatinib Mesylate 4 Ipilimumab 3 Cetuximab 3 pembrolizumab 2 palbociclib 2 Specimen Handling 2 Radiotherapy 2 Radiosurgery 2 Protons 2 Proton Therapy 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 tazemetostat 1 spartalizumab 1 relatlimab 1 nilotinib 1 camrelizumab 1 avelumab 1 atezolizumab 1 apatinib 1 Zoledronic Acid 1 X-Rays 1 Tiragolumab 1 Thiotepa 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Photochemotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Chordoma × Afatinib × Clear all

NCT03083678 2025-02-13

Afatinib in Locally Advanced and Metastatic Chordoma

Leiden University Medical Center

Phase 2 Completed

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡